HLS Therapeutics Inc.

TSX:HLS.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.76 -2.51%

-$0.11 today

Market cap
$116.32M
Beta
0.85
P/E (TTM)
-9.6
EPS (TTM)
-$0.33
52W Low $0.00High $5.77

Volume 0.04M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$137.28M

FY 2025 · Annual

-14.1% YoY

Liabilities

$75.72M

FY 2025 · Annual

-14.5% YoY

Equity

$61.56M

FY 2025 · Annual

-13.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents21.18M20.72M21.95M17.46M11.7M
Short-term Investments00000
Net Receivables11.51M11.19M10.69M7.53M7.85M
Inventory8.93M8.9M9.53M9.06M8.12M
Other Current Assets1.74M1.43M2K11.37M
Total Current Assets43.75M44.37M44.1M35.4M29.04M
Property, Plant & Equipment (Net)1.57M1.13M965K997K1.34M
Goodwill00000
Intangible Assets229.18M195.02M162.34M122.12M105.43M
Long-term Investments00000
Tax Assets690K465K1.04M857K1.14M
Other Non-current Assets714K668K1.66M528K327.41K
Total Non-current Assets232.15M197.28M164.97M124.5M108.24M
Total Assets275.91M241.65M209.06M159.9M137.28M
Account Payables9.32M11.59M14.11M8.71M10.42M
Short-term Debt12M13.06M4.69M4.83M4.33M
Tax Payables97K0281K152K0
Deferred Revenue4.85M0000
Other Current Liabilities901K6.02M7.14M8.4M10.43M
Total Current Liabilities27.67M31.19M26.69M22.55M26.07M
Long-term Debt84.13M83.28M82.05M60.74M44.37M
Deferred Tax Liabilities653K566K442K4.07M3.05M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.54M817K1.77M778K1.67M
Total Non-current Liabilities87.5M85.14M84.68M66.02M49.65M
Total Liabilities115.17M116.33M111.36M88.56M75.72M
Common Stock265.92M265.21M262.13M260.6M255.87M
Retained Earnings(119.86M)(148.45M)(175.46M)(194.18M)(203.78M)
Accumulated OCI2.96M(5.26M)(2.84M)(10.21M)(6.67M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity160.74M125.32M97.7M71.34M61.56M
Total Debt97.57M97.35M87.62M66.45M49.73M
Net Debt76.39M76.62M65.67M48.99M38.03M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$12.3M
Receivables$8.1M
Inventory$7.4M
Other Current$1.1M
Total Current Assets$29.0M
PP&E (Net)$1.2M
Intangible Assets$99.7M
Tax Assets$1.0M
Other Non-current$322.2K
Total Non-current Assets$102.2M
Total Assets$131.2M

Analysis

Selected assets total $131.2M for Latest. The largest visible component is Intangible Assets at $99.7M, about 76.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does HLS.TO have?

HLS Therapeutics Inc. (HLS.TO) reported $11.70M in cash and equivalents in fiscal 2025.

How much debt does HLS.TO carry?

HLS Therapeutics Inc. (HLS.TO) reported $49.73M of total debt, with net debt of $38.03M.